THU0364 Immunogenicity of Anti-TNF Drugs and Clinical Response in Patients With Spondyloarthritis

doi 10.1136/annrheumdis-2017-eular.5726
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ Publishing Group Ltd and European League Against Rheumatism

Related search

The Immunogenicity to the First Anti-TNF Therapy Determines the Outcome of Switching to a Second Anti-TNF Therapy in Spondyloarthritis Patients

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2013English

Letter: Immunogenicity of Anti-TNF in Elderly IBD Patients

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Letter: Immunogenicity of Anti-TNF in Elderly IBD Patients-Authors' Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

New Polymorphisms Associated With Response to Anti-TNF Drugs in Patients With Moderate-To-Severe Plaque Psoriasis

Pharmacogenomics Journal
Molecular MedicineGeneticsPharmacology
2016English

Cronkhite-Canada Syndrome: Sustained Clinical Response With Anti-TNF Therapy

Case Reports in Medicine
Medicine
2018English

Reduction of Autophagy and Increase in Apoptosis Correlates With a Favorable Clinical Outcome in Patients With Rheumatoid Arthritis Treated With Anti-TNF Drugs

Arthritis Research & Therapy
2019English

Clinical and Contrast-Enhanced Ultrasound Echography Outcomes in Psoriatic Arthritis Patients After One Year of Continuous Therapy With Anti-TNF Drugs

ISRN Dermatology
2014English

Profiling Response to TNF-Inhibitor Treatment in Axial Spondyloarthritis

Arthritis Care and Research
Rheumatology
2018English

THU0482 Evolution of Comorbid Fibromyalgia Frequency in Axial Spondyloarthritis Patients Starting an Anti-TNF Agent, and Correlation to Anti-TNF Efficacy. The Predict-Spa Study

2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy